115 related articles for article (PubMed ID: 10365651)
1. High-performance liquid chromatography method for analyzing the antiretroviral agent efavirenz in human plasma.
Villani P; Pregnolato M; Banfo S; Rettani M; Burroni D; Seminari E; Maserati R; Regazzi MB
Ther Drug Monit; 1999 Jun; 21(3):346-50. PubMed ID: 10365651
[TBL] [Abstract][Full Text] [Related]
2. High-performance liquid chromatographic method for the determination of HIV-1 non-nucleoside reverse transcriptase inhibitor efavirenz in plasma of patients during highly active antiretroviral therapy.
Langmann P; Schirmer D; Väth T; Zilly M; Klinker H
J Chromatogr B Biomed Sci Appl; 2001 May; 755(1-2):151-6. PubMed ID: 11393699
[TBL] [Abstract][Full Text] [Related]
3. Quantitative determination of efavirenz (DMP 266), a novel non-nucleoside reverse transcriptase inhibitor, in human plasma using isocratic reversed-phase high-performance liquid chromatography with ultraviolet detection.
Veldkamp AI; van Heeswijk RP; Meenhorst PL; Mulder JW; Lange JM; Beijnen JH; Hoetelmans RM
J Chromatogr B Biomed Sci Appl; 1999 Oct; 734(1):55-61. PubMed ID: 10574190
[TBL] [Abstract][Full Text] [Related]
4. Determination of efavirenz in human plasma by high-performance liquid chromatography with ultraviolet detection.
Saras-Nacenta M; López-Púa Y; Lípez-Cortés LF; Mallolas J; Gatell JM; Carné X
J Chromatogr B Biomed Sci Appl; 2001 Nov; 763(1-2):53-9. PubMed ID: 11710583
[TBL] [Abstract][Full Text] [Related]
5. Conventional HPLC method used for simultaneous determination of the seven HIV protease inhibitors and nonnucleoside reverse transcription inhibitor efavirenz in human plasma.
Takahashi M; Yoshida M; Oki T; Okumura N; Suzuki T; Kaneda T
Biol Pharm Bull; 2005 Jul; 28(7):1286-90. PubMed ID: 15997115
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous determination of the HIV protease inhibitors indinavir, amprenavir, saquinavir, ritonavir, nelfinavir and the non-nucleoside reverse transcriptase inhibitor efavirenz by high-performance liquid chromatography after solid-phase extraction.
Marzolini C; Telenti A; Buclin T; Biollaz J; Decosterd LA
J Chromatogr B Biomed Sci Appl; 2000 Mar; 740(1):43-58. PubMed ID: 10798293
[TBL] [Abstract][Full Text] [Related]
7. High-performance liquid chromatographic method for the simultaneous determination of the six HIV-protease inhibitors and two non-nucleoside reverse transcriptase inhibitors in human plasma.
Titier K; Lagrange F; Péhourcq F; Edno-Mcheik L; Moore N; Molimard M
Ther Drug Monit; 2002 Jun; 24(3):417-24. PubMed ID: 12021635
[TBL] [Abstract][Full Text] [Related]
8. Simple and rapid method for the simultaneous determination of the non-nucleoside reverse transcriptase inhibitors efavirenz and nevirapine in human plasma using liquid chromatography.
Kappelhoff BS; Rosing H; Huitema AD; Beijnen JH
J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jul; 792(2):353-62. PubMed ID: 12860043
[TBL] [Abstract][Full Text] [Related]
9. Simple and rapid liquid chromatography method for determination of efavirenz in plasma.
Ramachandran G; Kumar AK; Swaminathan S; Venkatesan P; Kumaraswami V; Greenblatt DJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 May; 835(1-2):131-5. PubMed ID: 16574512
[TBL] [Abstract][Full Text] [Related]
10. High-performance liquid chromatography assay for the determination of the HIV-protease inhibitor tipranavir in human plasma in combination with nine other antiretroviral medications.
Choi SO; Rezk NL; Kashuba AD
J Pharm Biomed Anal; 2007 Mar; 43(4):1562-7. PubMed ID: 17236737
[TBL] [Abstract][Full Text] [Related]
11. Simple and rapid quantification of the non-nucleoside reverse transcriptase inhibitors nevirapine, delavirdine, and efavirenz in human blood plasma using high-performance liquid chromatography with ultraviolet absorbance detection.
Rezk NL; Tidwell RR; Kashuba AD
J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Jul; 774(1):79-88. PubMed ID: 12052725
[TBL] [Abstract][Full Text] [Related]
12. Antiretrovirals: simultaneous determination of five protease inhibitors and three nonnucleoside transcriptase inhibitors in human plasma by a rapid high-performance liquid chromatography--mass spectrometry assay.
Villani P; Feroggio M; Gianelli L; Bartoli A; Montagna M; Maserati R; Regazzi MB
Ther Drug Monit; 2001 Aug; 23(4):380-8. PubMed ID: 11477320
[TBL] [Abstract][Full Text] [Related]
13. Rapid method for the quantitative determination of efavirenz in human plasma.
Mogatle S; Kanfer I
J Pharm Biomed Anal; 2009 Jul; 49(5):1308-12. PubMed ID: 19375262
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous quantitative assay of six HIV protease inhibitors, one metabolite, and two non-nucleoside reverse transcriptase inhibitors in human plasma by isocratic reversed-phase liquid chromatography.
Tribut O; Arvieux C; Michelet C; Chapplain JM; Allain H; Bentué-Ferrer D
Ther Drug Monit; 2002 Aug; 24(4):554-62. PubMed ID: 12142642
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous high-performance liquid chromatographic determination of the antiretroviral agents amprenavir, nelfinavir, ritonavir, saquinavir, delavirdine and efavirenz in human plasma.
Proust V; Toth K; Hulin A; Taburet AM; Gimenez F; Singlas E
J Chromatogr B Biomed Sci Appl; 2000 Jun; 742(2):453-8. PubMed ID: 10901152
[TBL] [Abstract][Full Text] [Related]
16. Determination of abacavir in human plasma by high-performance liquid chromatography with ultraviolet detection and the analytical error function.
Ferrer SM; Modamio P; Lastra CF; Mariño EL
Biomed Chromatogr; 2004 Dec; 18(10):862-5. PubMed ID: 15386566
[TBL] [Abstract][Full Text] [Related]
17. A fast and reliable reversed phase high performance liquid chromatography method for simultaneous determination of selected anti-retroviral and lumefantrine in human plasma.
Maganda B; Heudi O; Cortinovis A; Picard F; Kretz O; Minzi O
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Mar; 919-920():52-60. PubMed ID: 23411019
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous determination of six HIV protease inhibitors (amprenavir, indinavir, lopinavir, nelfinavir, ritonavir and saquinavir), the active metabolite of nelfinavir (M8) and non-nucleoside reverse transcriptase inhibitor (efavirenz) in human plasma by high-performance liquid chromatography.
Hirabayashi Y; Tsuchiya K; Kimura S; Oka S
Biomed Chromatogr; 2006 Jan; 20(1):28-36. PubMed ID: 15971289
[TBL] [Abstract][Full Text] [Related]
19. Performance analysis of a rapid HPLC determination with the solvent demixing extraction of HIV antiproteases and efavirenz in plasma.
Cociglio M; Hillaire-Buys D; Peyrière H; Alric R
J Chromatogr Sci; 2003 Feb; 41(2):80-6. PubMed ID: 12639255
[TBL] [Abstract][Full Text] [Related]
20. A validated method for quantification of efavirenz in dried blood spots using high-performance liquid chromatography-mass spectrometry.
Amara AB; Else LJ; Tjia J; Olagunju A; Puls RL; Khoo S; Back DJ
Ther Drug Monit; 2015 Apr; 37(2):220-8. PubMed ID: 25162217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
